R&D Lunch and Learn Series 2022 - Tabula Rasa HealthCare
Home > R&D Lunch and Learn Series 2022

R&D Lunch and Learn Webinar Series 2022

In this lunch and learn series of webinars, the TRHC Research and Development (R&D) team discusses their latest research surrounding better outcomes for pain management, the science behind medication safety, and much more. This series is designed to educate and inform participants on the latest research findings in medication safety and practice.

Upcoming Events

A Deprescribing Approach to Older Adults with Polypharmacy: Addressing Anticholinergic Drug Risk

When: Tuesday, August 9, 2022 | 1 p.m. to 2 p.m. ET

Medications with anticholinergic properties lead to higher health risk in older adults, especially those taking multiple medications. In this webinar, TRHC’s Clinical Research Scientist Sweilem B. Al Rihani, PharmD, PhD, and Research Pharmacist David Bankes, PharmD, BCGP, will discuss the different deprescribing approaches for strong anticholinergic drugs, specifically urinary antimuscarinics (UAMs), in this population.

By attending this webinar, you will learn about:

  • A review of anticholinergic activity of medications
  • Anticholingergic drug exposure and long-term risk
  • The impact of urinary antimuscarinics (UAMs) on medication risk in older adults
  • Deprescribing UAMs in older adults to address polypharmacy

Past Events

Medication Management through a Personalized Approach

When: Tuesday, August 9, 2022 | 1 p.m. to 2 p.m.


  • Dr. Veronique Michaud, TRHC’S Chief Operating Officer
  • Dr. Adriana Matos, Research Pharmacist, TRHC
  • Nicole M. Del Toro-Pagan, PharmD, BCPS, CMWA, Pharmacogenomics Pharmacist

Tabula Rasa HealthCare’s research and development team discusses the impact of pharmacogenomic (PGx) services in clinical practice. Patients taking multiple medications are at higher risk for drug-related problems; evaluating how their medications interact with their body can help prescribers optimize regimens.

By attending this webinar you will learn about:

  • The impact of PGx testing in personalized medicine
  • The clinical and economic value of PGx services
  • TRHC’s PGx approach

Learn more about the science behind medication safety

When: Tuesday, April 26, 2022 | 1 p.m. to 1:45 p.m. ET


  • Alan Stein, MD, PhD, Senior Vice President, Office of Healthcare Analytics, TRHC
  • David Bankes, PharmD, BCGP, Research Pharmacist, TRHC
  • Ankur Patel, MD, MBA, FAAP, Chief Medical Officer, TRHC

CareVention HealthCare‘s Ankur Patel, MD will interview author David Bankes, PharmD, BCGP and Alan Stein, MD, PhD on the significant findings on the recently published PACE Study on the Impact of Medication Risk Mitigation.

By attending this webinar you will learn about:

  • A peer-reviewed study in the journal Healthcare demonstrated that PACE organizations using CareKinesis services had significantly less year-to-year medical expenditures compared to the control group of PACE organizations not using these services.
  • PACE organizations using CareKinesis medication risk mitigation (MRM) services saved over $5,000 per participant annually in healthcare costs
  • Most of the cost containment – 76% – involved facility-related expenses (e.g., hospital admission, ED visits, skilled nursing)

Discover better outcomes for pain management

When: Tuesday, June 14, 2022 | 1 p.m. to 2 p.m. ET


  • Veronique Michaud, BPharm, MSc, PhD, Chief Operation Officer of TRHC Precision Pharmacotherapy Research & Development Institute
  • Ankur Patel, MD, MBA, FAAP, Chief Medical Officer, TRHC

Tabula Rasa HealthCare’s Ankur Patel, MD will interview Dr. Michaud on the latest findings on drug-related risk and intervention in pain management.

By attending this webinar you will learn about:

  • The impacts of opioid-specific drug interactions on healthcare outcomes and expenditures
  • Findings and insights on current opioid prescribing practices
  • The benefit of applying pharmacogenomics (PGx) for optimizing chronic pain management and drug therapy
  • A clinical case report analyzing the impact of PGx testing paired with clinical decision support on a patient’s medication regimen

Fill 1 Copy 2closeFill 5 Copy 4green-arrowhamburgerFill 7 Copy 4Fill 1 Copy 4pauseplaysearch-iconFill 3 Copy 4